Condition
Hormonal Contraception
Total Trials
6
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting3
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07115849Not ApplicableRecruiting
Effect of Different Sex Hormone Profiles for the Response to Physical Training
NCT06918873RecruitingPrimary
Quality of Life During Different Regimens of Combined Hormonal Contraceptives in Women of Reproductive Age
NCT03660046CompletedPrimary
Contraceptive Hormones, Immunity, and Microbiome Evaluation
NCT06223126UnknownPrimary
Stress Reactivity and Hormonal Contraception
NCT06222749Not ApplicableRecruiting
Oxytocin and Reward Processing in Women
NCT02529683Not ApplicableCompletedPrimary
Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya
Showing all 6 trials